XML 173 R41.htm IDEA: XBRL DOCUMENT
v3.22.4

Segment Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Segment Reporting [Abstract] |
Net Sales and Operating Profit by Segment |
|  | 2022 |  | 2021 |  | 2020
Net sales |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America(1) |  | $ | 3,816 |  |  | $ | 3,694 |  |  | $ | 3,741 |
Latin America |  | 3,982 |  |  | 3,663 |  |  | 3,418 |
Europe |  | 2,548 |  |  | 2,841 |  |  | 2,747 |
Asia Pacific |  | 2,826 |  |  | 2,867 |  |  | 2,701 |
Africa/Eurasia |  | 1,082 |  |  | 1,045 |  |  | 981 |
Total Oral, Personal and Home Care |  | 14,254 |  |  | 14,110 |  |  | 13,588 |
Pet Nutrition(2) |  | 3,713 |  |  | 3,311 |  |  | 2,883 |
Total Net sales |  | $ | 17,967 |  |  | $ | 17,421 |  |  | $ | 16,471 |
_________ (1) Net sales in the U.S. for Oral, Personal and Home Care were $3,511, $3,391 and $3,447 in 2022, 2021 and 2020, respectively. (2) Net sales in the U.S. for Pet Nutrition were $2,432, $2,018 and $1,712 in 2022, 2021 and 2020, respectively.
|  | 2022 |  | 2021 |  | 2020
Operating profit |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 761 |  |  | $ | 754 |  |  | $ | 988 |
Latin America |  | 1,108 |  |  | 1,012 |  |  | 975 |
Europe |  | 514 |  |  | 682 |  |  | 652 |
Asia Pacific |  | 737 |  |  | 844 |  |  | 773 |
Africa/Eurasia |  | 228 |  |  | 203 |  |  | 206 |
Total Oral, Personal and Home Care |  | 3,348 |  |  | 3,495 |  |  | 3,594 |
Pet Nutrition |  | 850 |  |  | 901 |  |  | 793 |
Corporate |  | (1,305) |  |  | (1,064) |  |  | (502) |
Total Operating profit |  | $ | 2,893 |  |  | $ | 3,332 |  |  | $ | 3,885 |
|  | 2022 |  | 2021 |  | 2020
Capital expenditures |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 66 |  |  | $ | 87 |  |  | $ | 65 |
Latin America |  | 121 |  |  | 118 |  |  | 104 |
Europe |  | 31 |  |  | 44 |  |  | 41 |
Asia Pacific |  | 60 |  |  | 50 |  |  | 51 |
Africa/Eurasia |  | 30 |  |  | 33 |  |  | 13 |
Total Oral, Personal and Home Care |  | 308 |  |  | 332 |  |  | 274 |
Pet Nutrition |  | 297 |  |  | 147 |  |  | 56 |
Corporate |  | 91 |  |  | 88 |  |  | 79 |
Total Capital expenditures |  | $ | 696 |  |  | $ | 567 |  |  | $ | 409 |
|  | 2022 |  | 2021 |  | 2020
Depreciation and amortization |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 106 |  |  | $ | 104 |  |  | $ | 101 |
Latin America |  | 93 |  |  | 88 |  |  | 81 |
Europe |  | 90 |  |  | 98 |  |  | 94 |
Asia Pacific |  | 89 |  |  | 96 |  |  | 95 |
Africa/Eurasia |  | 9 |  |  | 9 |  |  | 9 |
Total Oral, Personal and Home Care |  | 387 |  |  | 395 |  |  | 380 |
Pet Nutrition |  | 65 |  |  | 62 |  |  | 58 |
Corporate |  | 93 |  |  | 99 |  |  | 101 |
Total Depreciation and amortization |  | $ | 545 |  |  | $ | 556 |  |  | $ | 539 |
|  | 2022 |  | 2021 |  | 2020
Identifiable assets |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 4,012 |  |  | $ | 4,058 |  |  | $ | 4,132 |
Latin America |  | 2,603 |  |  | 2,369 |  |  | 2,251 |
Europe |  | 3,457 |  |  | 4,432 |  |  | 5,386 |
Asia Pacific |  | 2,085 |  |  | 2,161 |  |  | 2,272 |
Africa/Eurasia |  | 694 |  |  | 599 |  |  | 605 |
Total Oral, Personal and Home Care |  | 12,851 |  |  | 13,619 |  |  | 14,646 |
Pet Nutrition |  | 2,804 |  |  | 1,342 |  |  | 1,210 |
Corporate(1) |  | 76 |  |  | 79 |  |  | 64 |
Total Identifiable assets |  | $ | 15,731 |  |  | $ | 15,040 |  |  | $ | 15,920 |
____________ (1)In 2022, Corporate identifiable assets primarily consisted of investments in equity securities (95%). In 2021, Corporate identifiable assets primarily consisted of investments in equity securities (87%) and derivative instruments (10%). In 2020, Corporate identifiable assets primarily consisted of investments in equity securities (95%).
|  | 2022 |  | 2021 |  | 2020
Long-lived assets(1) |  |  |  |  |  |
United States |  | $ | 2,569 |  |  | $ | 1,981 |  |  | $ | 1,889 |
International |  | 2,216 |  |  | 2,275 |  |  | 2,348 |
Total Long-lived assets |  | $ | 4,785 |  |  | $ | 4,256 |  |  | $ | 4,237 |
____________ (1)Long-lived assets include Property, plant and equipment, net and lease right-of-use assets.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration